- Home
- PSIX vs SYRE Comparison
PSIX vs SYRE Comparison
Compare PSIX & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSIX
- SYRE
- Stock Information
- Founded
- PSIX 1985
- SYRE 2013
- Country
- PSIX United States
- SYRE United States
- Employees
- PSIX N/A
- SYRE N/A
- Industry
- PSIX Industrial Machinery/Components
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- PSIX Industrials
- SYRE Health Care
- Exchange
- PSIX Nasdaq
- SYRE Nasdaq
- Market Cap
- PSIX 801.5M
- SYRE 841.4M
- IPO Year
- PSIX N/A
- SYRE 2016
- Fundamental
- Price
- PSIX $42.50
- SYRE $15.40
- Analyst Decision
- PSIX Strong Buy
- SYRE Buy
- Analyst Count
- PSIX 1
- SYRE 6
- Target Price
- PSIX $37.00
- SYRE $55.00
- AVG Volume (30 Days)
- PSIX 321.8K
- SYRE 490.0K
- Earning Date
- PSIX 05-08-2025
- SYRE 05-08-2025
- Dividend Yield
- PSIX N/A
- SYRE N/A
- EPS Growth
- PSIX 172.88
- SYRE N/A
- EPS
- PSIX 3.53
- SYRE N/A
- Revenue
- PSIX $516,173,000.00
- SYRE N/A
- Revenue This Year
- PSIX $12.55
- SYRE N/A
- Revenue Next Year
- PSIX $8.36
- SYRE N/A
- P/E Ratio
- PSIX $12.05
- SYRE N/A
- Revenue Growth
- PSIX 17.92
- SYRE N/A
- 52 Week Low
- PSIX $4.33
- SYRE $10.91
- 52 Week High
- PSIX $45.74
- SYRE $40.26
- Technical
- Relative Strength Index (RSI)
- PSIX N/A
- SYRE 54.97
- Support Level
- PSIX N/A
- SYRE $14.75
- Resistance Level
- PSIX N/A
- SYRE $15.71
- Average True Range (ATR)
- PSIX 0.00
- SYRE 0.73
- MACD
- PSIX 0.00
- SYRE 0.12
- Stochastic Oscillator
- PSIX 0.00
- SYRE 80.50
About PSIX Power Solutions International Inc. Common Stock
Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction, and irrigation. The company generates majority of its sales from United States.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.